Citrate-positive variants of Escherichia coli have been isolated from human clinical specimens (17) or non-human specimens (4, 5) . Citrate-utilizing (Cit) abilities in citrate-positive E. coli variants isolated from pigeons, pigs, and cattle in Japan were mediated by transmissible plasmids and were always associated with drug resistance determinants (4, 11) . Ishiguro and Sato (6) also reported that 67 citrate-positive E. coli variants were isolated from various specimens from humans, domestic animals, birds, and the environment during an extensive survey, and most of them carried conjugative Cit plasmids. Regarding Salmonella strains, 12 thermosensitive Hi plasmids from Salmonella typhi strains isolated in Vietnam, Thailand, and India mediated citrate utilization in an E. coli K-12 strain (14) . Thus, transmissible or nontransmissible citrate utilization has been found in E. coli and S. typhi strains isolated in a number of countries, including Japan (4, 6, 7, 13, 14) . It is of particular interest that the conjugal transfer of Cit abilities is thermosensitive and concurrent with transfer of drug resistance.
Since thermosensitive H plasmids conferring drug resistance were isolated from Salmonella typhimurium strains of bovine origin at Japan at high rates during the last decade (S. Makino et al., unpublished data), we investigated the distribution of the conjugally transferred Cit character to E. coli strains among citrate-positive Salmonella strains isolated from cattle in Japan.
Recently, we were able to isolate and characterize Cit plasmids derived from Salmonella strains of bovine origin. However, attempts to detect the transferable Cit character in Proteus spp., Serratia spp., Klebsiella spp., Enterobacter spp., and Citrobacter spp. of human or bovine origin were unsuccessful.
MATERIALS AND METHODS Bacterial strains and phages. A total of 319 Salmonella strains examined in the present study were isolated from 22 cattle farms in northern Japan from 1970 to 1979 (Table 1) . These 22 farms, most of which were calf-rearing farms, were epidemiologically unrelated. All strains except a strain of Salmonella bredeney were S. typhimurium. Of 318 S. typhimurium strains, 181 were S. typhimurium Copenhagen variety. These strains had been isolated and stored on Dorset egg slopes at ambient temperature in our laboratory. The strains of S. typhimurium isolated from farm A were obtained at a feedlot after repeated longterm examinations (12) . The 318 strains (except 3 strains of S. typhimurium) were resistant to one or more antibiotics, including ampicillin (Ap), chloramphenicol (Cm), kanamycin (Km), streptomycin (Sm), tetracycline (Tc), and sulfonamides (Su).
Enterobacterial strains other than Salmonella strains were also examined for transmissible Cit ability. The 16 transconjugants of E. coli W3630 carrying R plasmids derived from Proteus rettgeri or Proteus mirabilis, which were isolated from clinical specimens and from sewage, were supplied by S. Mitsuhashi (10) . Of these, six transconjugants carried thermosensitive V plasmids. The 31 strains of Serratia marcescens, supplied by S. Kimura, were isolated from clinical materials of human source at five different hospitals. These S. marcescens strains were resistant to three or more drugs including Ap, Cm, Km, Sm, Su, and Tc, and most of them carried conjugative R plasmids. Among the conjugative R plasmids detected, three were IncA-C and four were IncM as identified by incompatibility tests. Five S. marcescens strains, 2 Serratia liquefaciens strains, 13 Klebsiella pneumoniae strains, 6 Klebsiella oxytoca strains, 11 Enterobacter cloacae strains, 5 Enterobacter aerogenes strains, and 1 Citrobacterfreundii strain were supplied by T. Kume. These strains were isolated from specimens of clinical bovine mastitis, and some of them were resistant to one or two drugs, such as Ap, Sm, and Tc; however, none of them carried conjugative R plasmids.
The initial recipient of the Cit character of these strains was E. coli K-12 ML1410, a nalidixic acidresistant strain requiring methionine (11) . A subsequent recipient of the Cit character was E. coli K-12 SG1 (rifampin-resistant mutant of E. coli W1895 [Hfr met]) (4). E. coli Row was used as the indicator strain for testing colicin production (6) . The male-specific phages fl and f2 were used for fertility inhibition (Fi) tests.
Media. Penassay broth (Difco) was used for conjugation experiments. The selective media used for citrate utilization were Simmons citrate agar (Eiken) plates, which were supplemented with methionine (50 jg/ml) and either nalidixic acid (50 ,g/ml) or rifampin (50 ,g/ml) when necessary (11) . Bromothymol bluelactose agar was used as the selective medium for Tc (25 pg/ml) and Cm (25 ug/ml) (4). To examine drug resistance of the strain or the resistance patterns of transconjugants, heart infusion agar (Eiken) was used as the basal medium for susceptibility testing of Ap (25 pg/ml), Cm (25 ,ug/ml), Km (25 pg/ml), Sm (12.5 pg/ml), and Tc (25 pg/ml), and Mueller-Hinton agar (Eiken) was used for that of Su (800 pg/ml) (5) . Heart infusion agar was also used as the nutrient agar for mercury (lOg of HgC12 per ml) or teliurite (potassium tellurite) resistance tests. L broth (8), L broth agar, and L broth soft agar were used for growth and titration of phages. In the present study, CaCl2 was added to L broth or L broth agar at a final concentration of 2.5 x 10-3 M. The basal agar medium used for testing organic acid utilization consisted of 7 g of K2HPO4, 3 g of KH2PO4, 1 g of (NH4)2S04, 1 g of MgSO4. 7H20, 50 mg of methionine, 15 g of agar (Difco), and 1,000 ml of distilled water (3) .
Transfer experiments on Cit ability. The donor strain, a citrate-positive enterobacterial strain, and the recipient of E. coli ML1410 were separately precultured in 2 ml of Penassay broth at 28°C for 18 h. Two milliliters of broth was inoculated with 0.2 ml of each donor broth culture and 0.5 ml of recipient culture. The duplicate mixed cultures were separately incubated at 28 and 37°C for 18 h. A loopful of each mixed culture was subcultured onto Simmons citrate agar containing methionine and nalidixic acid. These subcultured selective media were incubated at 37°C for 4 days. To determine transconjugant recipients and their characters, five colonies grown on selective Simmons citrate agar were purified by successive singlecolony isolations on the same selective media and were examined for drug resistance pattern, mercury and tellurite resistance, and colicin and hemolysin production. If the transconjugant colony was not detected by the mating culture made at 37°C, or if the transconjugant was more easily detected by the mating culture made at 28°C than that made at 37°C, donor strains were assumed to carry a thermosensitive plasmid conferring the Cit character. In these cases, to further investigate transfer of the Cit character, quantitative transfer experiments were also done as described previously (6, 11) .
Antibiotic susceptibility test and mercury and tellurite resistance tests. Antibiotic susceptibility testing of transconjugants of E. coli ML1410 selected for the Cit character was done as previously described (5) . The transconjugants were also tested for resistance to mercury and tellurite. The method used for mercury resistance tests was that described by Nakahara et al. (9) . Resistance to tellurite was tested in E.
coli ML1410 by the method of Summers and Jacoby (15) .
Examination for hemolysin and colicin production. E. coli ML1410 transconjugants carrying the Cit character were tested for the production of hemolysin or colicin as previously described (6) . E. coli Row was used as the indicator strain.
Fi tests. The Cit character to be tested was transmitted to E. coli SG1 from ML1410 carrying this character. The Fi character of the Cit plasmid was examined by the surface spot method, using malespecific phages fl and f2 (4 
